Novel pyrrolidine derived beta 3 adrenergic receptor agonists

Details for Australian Patent Application No. 2010286694 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Edmondson, Scott D.; Chang, Lehua; Kar, Nam Fung; Morriello, Gregori J.; Moyes, Christopher J.; Shen, DongMing; Zhu, Cheng; Anthony, Neville J.; Jones, Philip; Smith, Graham F.; Scott, Mark E.; Thompson, Christopher F.; Jung, Joon; Cammarano, Carolyn; Hoffman, Dawn Marie

Agent Spruson & Ferguson

Pub. Number AU-A-2010286694

PCT Pub. Number WO2011/025774

Priority 61/237,487 27.08.09 US

Filing date 24 August 2010

Wipo publication date 3 March 2011

International Classifications

A01N 43/38 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

Event Publications

8 March 2012 PCT application entered the National Phase

  PCT publication WO2011/025774 Priority application(s): WO2011/025774

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010286696-Devices, methods, and systems for prosthetic meniscus selection, trialing, and implantation

2010286691-Condensed quinolines as protein kinase modulators